Home/ Supplements/ Phosphorus/ Whey To Go Whey Protein Powder Chocolate

Whey To Go Whey Protein Powder Chocolate

product on market Powder Solgar Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 18% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Whey protein is supported by strong evidence for promoting muscle protein synthesis and supporting lean mass recovery. The profile consists of standard macronutrients that provide essential amino acids and energy. Research indicates these components are generally safe for consumption within recommended dietary limits.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Whey To Go Whey Protein Powder Chocolate
Open Full PDF View on NIH DSLD →
Details

Label Data

35 Gram(s)
Serving Size
Amino acid/Protein
Product Type
18%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
140 Calorie(s)
Total Fat
1 Gram(s) (2% DV)
Cholesterol
10 mg (3% DV)
Total Carbohydrates
11 Gram(s) (4% DV)
Protein
20 Gram(s) (40% DV)
Calcium
80 mg (8% DV)
Iron
0.5 mg (3% DV)
50 mg (5% DV)
Within RDA (0.1× RDA) 13 studies (A:0, B:3)
20 mg (5% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
Sodium
75 mg (3% DV)
Potassium
200 mg (6% DV)

Other Ingredients

Whey Protein isolate Fruit Sugar Whey Protein concentrate Dutch Cocoa Natural flavors L-Glutamine Free-form BCAA's Contains Less Than 1% of
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement for adults, mix 35 grams in 8 ounces of water or your preferred source of milk and blend or shake vigorously. Please note the additional calories and /or protein provided by your favorite type of milk.

Warnings & Precautions

Notice: Use this product as a food supplement only. Do not use for weight reduction.

If you are pregnant, nursing, taking any medications or have any medical condition, please consult your healthcare practitioner before taking any dietary supplement.

Discontinue use and consult your healthcare practitioner if any adverse reactions occur.

Keep out of reach of children.

Do not use if packet is torn or open.

Contains milk and soy.

Formulation Notes

rBGH free Gluten free

Mixes easily for smooth taste

No artificial sweeteners

Suitable for lacto-vegetarians

Chocolate Naturally flavored 20g protein per serving

With other natural flavors

This product is manufactured from cows not treated with rBGH, recombinant bovine growth hormone. No significant difference has been shown between milk derived from rBGH treated cows and untreated cows.

Additional Information

Store at room temperature.

Metadata

Product Details

UPC / SKU0 33984 67173 7
DSLD Entry Date2020-02-26
Product TypeAmino acid/Protein
FormPowder
BrandSolgar
DSLD ID214464
Data Updated2026-04-11
Research

Research Evidence

46
Research Sources
55
Avg Quality
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020 PubMed DOI
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018 PubMed DOI
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022 PubMed DOI
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022 PubMed DOI
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024 PubMed DOI
View all evidence for Phosphorus →
Compare

Similar Products

View all Phosphorus products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.